Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

fool.com - TMF Breakfast News - Breakfast News: Pharma's $400B Blockbuster Brewing
Breakfast News: Pharma's $400B Blockbuster Brewing
The Motley Fool

Fuel cell maker Bloom Energy (BE -0.63%) entered the Supernova Odyssey portfolio in December, just as it was becoming a critical supplier of power generation to the data center buildout. Following a drawdown from its November 2025 high, the stock…

thehindubusinessline.com - GSK Pharma Q1 profit up 16% at ₹237.18 cr
GSK Pharma Q1 profit up 16% at ₹237.18 cr
BusinessLine

GlaxoSmithKline Pharmaceuticals Ltd on Monday reported a 16 per cent rise in consolidated net profit to ₹237.18 crore in the first quarter ended June 30, 2026. The company had posted a consolidated net profit of ₹205 crore in the…

thehindubusinessline.com - Sun Pharma voluntarily recalls 11 eyedrops from domestic market, experts seek details
Sun Pharma voluntarily recalls 11 eyedrops from domestic market, experts seek details
BusinessLine

Drugmaker Sun Pharmaceutical Industries has undertaken a voluntary recall of some of its ophthalmic products in the domestic market, with reports suggesting that 11 eyedrops were withdrawn. While the voluntary action is being appreciated, public…

thehindubusinessline.com - Iran talks, crude crash fuel midday rally; IT joins financials at the top, pharma bleeds
Iran talks, crude crash fuel midday rally; IT joins financials at the top, pharma bleeds
BusinessLine

Markets held firm through the first half of Monday's session, with the Sensex trading at 78,719.67, up 625.03 points or 0.80 per cent, and the Nifty 50 at 24,588.35, up 204.75 points or 0.84 per cent, as of 1.30 PM. The gains, which built on a…

thehindubusinessline.com - Sensex, Nifty gap up on Iran diplomacy, crude slide; financials lead, pharma drags
Sensex, Nifty gap up on Iran diplomacy, crude slide; financials lead, pharma drags
BusinessLine

Benchmarks opened sharply higher on Monday, August 3, 2026, as easing geopolitical tensions in West Asia and a fall in crude oil prices lifted investor sentiment across the financial and consumer sectors, even as pharmaceutical and auto stocks…

marketbeat.com - Carmignac Gestion Purchases Shares of 631,200 Royalty Pharma PLC $RPRX
Carmignac Gestion Purchases Shares of 631,200 Royalty Pharma PLC $RPRX
MarketBeat

Carmignac Gestion purchased a new position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased…

marketbeat.com - Defilade Capital Management L.P. Lowers Position in Ascendis Pharma A/S $ASND
Defilade Capital Management L.P. Lowers Position in Ascendis Pharma A/S $ASND
MarketBeat

Defilade Capital Management L.P. lessened its holdings in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 39.4% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission.

marketbeat.com - Quantinno Capital Management LP Buys 41,417 Shares of Royalty Pharma PLC $RPRX
Quantinno Capital Management LP Buys 41,417 Shares of Royalty Pharma PLC $RPRX
MarketBeat

Quantinno Capital Management LP increased its position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 12.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm…

wsj.com - Health Care Roundup: Market Talk
Health Care Roundup: Market Talk
Wall Street Journal

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0811 GMT – A potential tie-up between AstraZeneca and Bristol Myers Squibb could face antitrust hurdles…

marketbeat.com - The Manufacturers Life Insurance Company Buys 219,772 Shares of Royalty Pharma PLC $RPRX
The Manufacturers Life Insurance Company Buys 219,772 Shares of Royalty Pharma PLC $RPRX
MarketBeat

The Manufacturers Life Insurance Company raised its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 244.3% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned…

marketbeat.com - Dimensional Fund Advisors LP Has $51.67 Million Holdings in Royalty Pharma PLC $RPRX
Dimensional Fund Advisors LP Has $51.67 Million Holdings in Royalty Pharma PLC $RPRX
MarketBeat

Dimensional Fund Advisors LP lessened its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 53.4% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The…

axios.com - Mike Allen - New Yorker: China races to own the industries of the future
New Yorker: China races to own the industries of the future
Axios

America has been napping or distracted by trivialities while China is racing toward the future, in part by taking advantage of President Trump's trade, immigration and budget policies. That's the eye-opening reality that Evan Osnos unfurls in a…

rediff.com - Rediff News - Stock markets take winning run to 4th day
Stock markets take winning run to 4th day
Rediff.com

Stock market benchmark indices ended higher on Monday, with the Sensex climbing 544.39 points and Nifty surging 1.60 per cent, following a sharp decline in crude oil prices amid easing geopolitical tensions. Foreign fund inflows also added to…

seekingalpha.com - Manshi Mamtora - Germany leads European market rise as PMI strengthens, oil prices ease (EUR:USD:)
Germany leads European market rise as PMI strengthens, oil prices ease (EUR:USD:)
Seeking Alpha

European stocks, including the DAX's record high, are buoyed by improved manufacturing PMIs and lower oil prices, but gains are limited by weak energy and pharma sectors. Falling bond yields in major European economies and local currency softness…

newyorker.com - Evan Osnos - The Future, Made in China
The Future, Made in China
The New Yorker

Kai-Fu Lee, the C.E.O. of the artificial-intelligence company 01.AI, lives in a mirrored high-rise in Beijing, near a procession of landmarks that emperors considered the center of the cosmos. Lee takes early meetings at a nearby hotel that could…

Receive a Daily briefing on Pharma Industry News

Get Started